Share on StockTwits

USANA Health Sciences (NASDAQ:USNA) Insider Dave Wentz unloaded 5,141 shares of the stock in a transaction that occurred on Monday, August 25th. The shares were sold at an average price of $73.30, for a total value of $376,835.30. Following the completion of the sale, the insider now directly owns 473,955 shares of the company’s stock, valued at approximately $34,740,902. The sale was disclosed in a document filed with the SEC, which can be accessed through this link.

Shares of USANA Health Sciences (NASDAQ:USNA) traded down 0.16% during mid-day trading on Monday, hitting $73.61. 127,812 shares of the company’s stock traded hands. USANA Health Sciences has a 52-week low of $55.01 and a 52-week high of $92.00. The stock has a 50-day moving average of $71.44 and a 200-day moving average of $73.09. The company has a market cap of $955.8 million and a price-to-earnings ratio of 14.53.

USANA Health Sciences (NASDAQ:USNA) last posted its quarterly earnings results on Tuesday, July 29th. The company reported $1.36 EPS for the quarter, missing the Thomson Reuters consensus estimate of $1.50 by $0.14. The company had revenue of $188.30 million for the quarter, compared to the consensus estimate of $198.30 million. During the same quarter in the previous year, the company posted $1.72 earnings per share. The company’s revenue for the quarter was down .4% on a year-over-year basis. Analysts expect that USANA Health Sciences will post $5.56 EPS for the current fiscal year.

USANA Health Sciences, Inc develops and manufactures science-based nutritional and personal care products.

Receive News & Ratings for USANA Health Sciences Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for USANA Health Sciences Inc and related companies with Analyst Ratings Network's FREE daily email newsletter.